BRAF inhibitor vemurafenib improves the antitumor activity of adoptive cell immunotherapy.
暂无分享，去创建一个
T. Graeber | A. Ribas | Stephen Mok | N. Graham | R. Koya | T. Chodon | P. Tumeh | N. Otte | Begonya Comin-Anduix | Aspram Minasyan | Kevin J. Blacketor